if you register then you will see a webcast where Oxfordbio present and give details of their application for Prosavin, (Q3 2007), and plans to initiate phase 1/2 (Q4 07). They then intend to go straight to phase 3 claiming results are visible in 3 months.

Good stuff this and Trovax, their lead product for Cancer, is performing well.

Pleased you resisted the urge to mention the cricket and rugby, our day will come.

Neil.